Related Experiment Videos
Organic transformations catalyzed by engineered yeast cells and related systems
1Department of Chemistry, University of Florida, Gainesville 32611, USA. jds2@chem.ufl.edu
Current Opinion in Biotechnology
|September 7, 2000
Summary
Baker's yeast (Saccharomyces cerevisiae) is key for asymmetric ketone reductions. Genome data now enhances stereoselectivity, while new enzymes enable chiral ketone oxidations.
Area of Science:
- Biocatalysis and Organic Synthesis
- Enzymology and Molecular Biology
Background:
- Baker's yeast (Saccharomyces cerevisiae) is widely used for asymmetric ketone reductions in organic synthesis.
- Traditional methods for improving stereoselectivity often involve selective inhibition.
- Recent advances leverage genomic data to refine yeast-based catalytic processes.
Purpose of the Study:
- To explore the impact of genome sequencing data on improving stereoselectivity in yeast-mediated asymmetric ketone reductions.
- To expand the catalytic capabilities of yeast beyond reductions.
Main Methods:
- Utilizing data from the Saccharomyces cerevisiae genome sequencing project to guide improvements in stereoselectivity.
- Employing selective inhibition techniques.
- Overexpressing a bacterial Baeyer-Villiger monooxygenase to introduce new catalytic functions.
Main Results:
- Genome data is beginning to enhance the stereoselectivity of asymmetric ketone reductions.
- The catalytic repertoire of yeast has been successfully expanded.
- Chiral ketone oxidations are now achievable through yeast biocatalysis.
Conclusions:
- Genomic insights are revolutionizing yeast biocatalysis for asymmetric synthesis.
- Baker's yeast offers a versatile platform for both ketone reductions and oxidations.
- This work expands the synthetic utility of Saccharomyces cerevisiae in organic chemistry.